SCHEMBL14730259

SCHEMBL14730259

CCN(C(=O)c1cnc(N2C[C@H](NC(=O)OC(C)(C)C)[C@@H](c3cc(C)ccc3F)C2)nc1)C1CCN(c2nc(C(C)(F)F)no2)CC1

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.36
NR1H2 P55055 2/20 0.32
GPR119 Q8TDV5 6/20 0.32
SYK P43405 1/20 0.32
HDAC4 P56524 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
KCNH2 Q12809 2/20 0.31
EIF2AK4 Q9P2K8 1/20 0.31
NR1H3 Q13133 1/20 0.31
SCN9A Q15858 1/20 0.31
SCN10A Q9Y5Y9 1/20 0.31
EGFR P00533 1/20 0.31
KCNE1 P15382 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14730318 0.94 NTRK1 (0.34) NR1H2GPR119HDAC4HDAC6KCNH2
SCHEMBL14730268 0.93 GPR119 (0.35) NR1H2GPR119SYKHDAC4HDAC6
SCHEMBL14730257 0.92 GPR119 (0.32) PDK2GPR119HDAC4HDAC6KCNH2
SCHEMBL14730256 0.92 PDK2 (0.34) PDK2NR1H2GPR119SYKHDAC4
SCHEMBL14730219 0.92 PDK2 (0.36) PDK2NR1H2GPR119SYKHDAC4
SCHEMBL14730173 0.91 PDK2 (0.34) PDK2NR1H2SYKEIF2AK4NR1H3
SCHEMBL14730217 0.91 GPR119 (0.34) PDK2NR1H2GPR119KCNH2EIF2AK4
SCHEMBL14730212 0.90 NTRK1 (0.33) NR1H2GPR119HDAC4HDAC6KCNH2
SCHEMBL14730174 0.89 PDK2 (0.33) PDK2NR1H2GPR119EIF2AK4NR1H3
SCHEMBL14730255 0.88 PDK2 (0.34) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed